Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Progress in Reducing Benzodiazepine Use Among Older Americans Stalled

July 6, 2026 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency

July 6, 2026 - Grantee/Partner News

  • Bespoke Gene Therapy Consortium (BGTC)

The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.

AI-Guided Pathology Analysis Can Help Predict Immunotherapy Response in Rare Cancers

June 30, 2026 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

How Repurposing a Drug May Help Treat More Rare Gastrointestinal Diseases

June 29, 2026 - NCATS News

  • Rare Diseases Clinical Research Network (RDCRN)

RDCRN researchers found that dupilumab — a drug used for asthma and chronic obstructive pulmonary disease — shows promise in treating eosinophilic gastritis.

NIDCR Prepares First-in-Human Trial for Jansen’s Disease Therapy

June 25, 2026 - Media Coverage

  • Our Impact on Rare Diseases
  • Translational Science

New UCLA Health Study Finds Urine Test May Spot Pregnancy Risks Before Symptom Onset

June 23, 2026 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

Last updated on September 29, 2026